Frédérique Végran

9PUBLICATIONS
35CO-AUTHORS
Innate immunityMedical biochemistry - lipidsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 22, 2026
IL-10 secretion by CD8 T cells orchestrates early NK cell recruitment and antitumor immunity after anti-VEGFR-2/PD-1 therapy.

|Jan 16, 2026
Stearoyl-CoA desaturase-1 controls the differentiation and antitumoral function of Th9 lymphocytes.

Emma Groetz, Sabrina Perrey, Alvaro Baeza Garcia

|Apr 08, 2025
The intrinsic expression of NLRP3 in Th17 cells promotes their protumor activity and conversion into Tregs.

Théo Accogli, Christophe Hibos, Lylou Milian

|Jun 28, 2023
GTN Enhances Antitumor Effects of Doxorubicin in TNBC by Targeting the Immunosuppressive Activity of PMN-MDSC.

Nesrine Mabrouk, Cindy Racoeur, Jingxuan Shan

|May 28, 2022
Role of Cytokines and Chemokines in Angiogenesis in a Tumor Context.

Mannon Geindreau, Mélanie Bruchard, Frédérique Vegran

|May 25, 2022
Hematopoietic Prostaglandin D2 Synthase Controls Tfh/Th2 Communication and Limits Tfh Antitumor Effects.

Romain Mary, Fanny Chalmin, Théo Accogli

Pageof 2

Frequent Collaborators

5 joint publications

François Ghiringhelli

3 joint publications

Romain Boidot

3 joint publications

Catherine Paul

3 joint publications

Mélanie Bruchard